Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Creganna Medical Opens State-Of-The-Art Manufacturing Hub In Plymouth, Minnesota

11/19/2015
A company that specializes in the design and manufacture of minimally invasive delivery and access devices for a range of therapies, Creganna Medical significantly expanded its operations in Plymouth, Minnesota. The company opened a new state-of-the-art manufacturing facility.

The 300 person Plymouth complex provides braid, coil and associated technologies for catheter and sheath devices including complex sub-assemblies and components. Coinciding with the site expansion is the addition of expanded engineering capacity to support medical device products from prototyping to high volume commercial manufacturing. To enable rapid response for product development, investment in a dedicated R&D unit has been made, encompassing an independent technical lab, collaborative prototyping zone and support cleanroom.

According to company officials the new plant, located at 5905 Trenton Lane North, is a custom 100,000 sq. ft. facility that triples Creganna Medical’s existing manufacturing footprint in Minnesota and greatly expands the company’s capacity to serve medical device customers for braid, coil and other minimally invasive device technologies.

Along with a multi-million dollar investment in the development of the new facility, the company expects to hire an additional 50 staff to support ongoing expansion at the site over the next 18 months.

“The opening of this new facility marks an important milestone in our continued global expansion,” commented Chip Hance, CEO, Creganna Medical. “Our investment highlights our commitment to supporting customers served from our Minnesota site as we keep in tandem with their increasing demand for our solutions. As our global Center of Excellence for Structural Heart and Electrophysiology therapies, the expansion of this site also enables Creganna Medical to remain at the forefront of design and manufacturing services for these key growth markets.”

The new facility deepens Creganna Medical’s R&D, manufacturing and commercial presence in Minnesota, a critical US cluster for the minimally invasive medical device industry and home to an estimated 700 medical device companies, company officials said.

“The company’s investment reflects the continued growth in demand for our technologies, the reputation of our Minnesota operations within the global Creganna Medical network and is a testament to the dedication of our local team”, said Brent Anderson, General Manager of Creganna Medical, Plymouth. “We look forward to the future as we scale, provide customers with a wider breadth of solutions and add new talent to our team.”

Exclusive Research